01 6Teva Canada Innovation
01 22191088
02 22702437
03 22760802
01 4GLATIRAMER ACETATE
02 2Glatiramer Acetate
01 1Powder for Solution
02 4SOLUTION
03 1Solution
01 22015-05-23
02 22028-11-26
03 22030-08-19
Patent Expiration Date : 2015-05-23
Date Granted : 2004-09-28
Brand Name : COPAXONE
Patent Number : 2191088
Filing Date : 1995-05-23
Strength per Unit : 20 mg / vial
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2015-05-23
Date Granted : 2004-09-28
Patent Expiration Date : 2015-05-23
Date Granted : 2004-09-28
Brand Name : COPAXONE
Patent Number : 2191088
Filing Date : 1995-05-23
Strength per Unit : 20 mg / 1ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2015-05-23
Date Granted : 2004-09-28
Patent Expiration Date : 2028-11-26
Date Granted : 2013-06-25
Brand Name : COPAXONE
Patent Number : 2702437
Filing Date : 2008-11-26
Strength per Unit : 40mg / 1mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2028-11-26
Date Granted : 2013-06-25
Patent Expiration Date : 2030-08-19
Date Granted : 2016-01-12
Brand Name : COPAXONE
Patent Number : 2760802
Filing Date : 2010-08-19
Strength per Unit : 40mg / 1mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2030-08-19
Date Granted : 2016-01-12
Patent Expiration Date : 2028-11-26
Date Granted : 2013-06-25
Brand Name : COPAXONE
Patent Number : 2702437
Filing Date : 2008-11-26
Strength per Unit : 40 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2028-11-26
Date Granted : 2013-06-25
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2030-08-19
Date Granted : 2016-01-12
Brand Name : COPAXONE
Patent Number : 2760802
Filing Date : 2010-08-19
Strength per Unit : 40 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2030-08-19
Date Granted : 2016-01-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
